In addition, our present findings point to a significant role of the mesothelium cell-layer, and demonstrate distinct alterations in CKD and during PD, with CLDN2 abundance independently predicting transperitoneal small solute transport rates. This evidence concerns the gene CLDN2 and chronic kidney disease.